When theory meets experiment: the PD-1 challenge

被引:4
|
作者
Ahmed, Marawan [1 ]
Barakat, Khaled [1 ,2 ,3 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada
[2] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada
[3] Univ Alberta, Li Ka Shing Appl Virol Inst, Edmonton, AB, Canada
关键词
Protein-protein interactions; Protein-protein docking; ZDOCK; hPD-1/hPD-L1; PROTEIN-PROTEIN INTERACTIONS; MOLECULAR-DYNAMICS; CAPRI EXPERIMENT; DOCKING; PREDICTION; IMMUNOTHERAPY; RECEPTOR; HADDOCK;
D O I
10.1007/s00894-017-3482-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Applying atomistic computational modeling to drug discovery has proven to be a hugely successful approach, allowing drug-receptor interactions to be predicted and drugs to be optimized for potency, selectivity, and safety. However, when it comes to predicting protein-protein interactions and to rationally designing regulators of these interactions, computational tools often fail. Here, we report one of the rare instances where state-of-the-art computer simulations, guided by experiment, were able to correctly predict one of the most sophisticated protein- protein interactions. We revisit our previous discovery of the complex of human PD-1 with the ligand PD-L1 and compare our earlier findings with the recently published crystal structure of the same complex. Side-byside comparison of the model of the complex with its crystal structure reveals outstanding agreement and suggests that our protein-protein prediction workflow could be applied to similar problems.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [32] Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys
    Pan, Enxiang
    Feng, Fengling
    Li, Pingchao
    Yang, Qing
    Ma, Xiuchang
    Wu, Chunxiu
    Zhao, Jin
    Yan, Hongbin
    Chen, Rulei
    Chen, Ling
    Sun, Caijun
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [33] PD-1 expression by canine T cells and functional effects of PD-1 blockade
    Coy, J.
    Caldwell, A.
    Chow, L.
    Guth, A.
    Dow, S.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1487 - 1502
  • [34] IS THERE A ROLE FOR INCREASED PD-1 AND PD-1 LIGAND EXPRESSIONS AFTER SEPTIC SHOCK?
    Guignant, Caroline
    Venet, Fabienne
    Lepape, Alain
    Monneret, Guillaume
    SHOCK, 2009, 32 : 20 - 20
  • [35] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [36] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    Leukemia, 2015, 29 : 2110 - 2113
  • [37] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [38] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Wang, Rui-na
    Yu, Qian
    Wang, Xiao-bo
    Zhu, Di
    Li, Guo-long
    Li, Zeng-xia
    Jiang, Wei
    Li, Wei
    Dang, Yong-jun
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (10) : 2103 - 2112
  • [39] PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
    Xu-Monette, Zijun Y.
    Zhou, Jianfeng
    Young, Ken H.
    BLOOD, 2018, 131 (01) : 68 - 83
  • [40] Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1
    Rui-na Wang
    Qian Yu
    Xiao-bo Wang
    Di Zhu
    Guo-long Li
    Zeng-xia Li
    Wei Jiang
    Wei Li
    Yong-jun Dang
    Acta Pharmacologica Sinica, 2023, 44 : 2103 - 2112